Pure Global

Automated Cell Separation and Manufacturing System - Vietnam Registration 2402051ĐKLH/BYT-HTTB

Access comprehensive regulatory information for Automated Cell Separation and Manufacturing System in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại C medical device is registered under number 2402051ĐKLH/BYT-HTTB and manufactured by Miltenyi Biotec B.V & Co. KG. The authorized representative in Vietnam is CÔNG TY TNHH B.C.E VIỆT NAM.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
300,000+ Devices
2402051ĐKLH/BYT-HTTB
Registration Details
Vietnam MOH Registration: 2402051ĐKLH/BYT-HTTB
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Automated Cell Separation and Manufacturing System
VN: Hệ thống tách và sản xuất tế bào tự động
Risk Class TTBYT Loại C

Registration Details

2402051ĐKLH/BYT-HTTB

000.00.04.G18-230307-0027

CliniMACS Prodigy

200-075-301

Company Information

GERMANY

Miltenyi Biotec B.V & Co. KG

Technical Details

1. The CliniMACS Prodigy Cell Separation System, which includes the CliniMACS Prodigy Components, CliniMACS Reagent Chemicals, CliniMACS Prodigy Pipette Set, CliniMACS PBS/EDTA Buffer and other accessories used in combination, is designed for in vitro separation of specific cells for clinical applications. 2. The CliniMACS Prodigy System for Gene Therapy and Cell Therapy is intended for use in ex vivo genetic manipulation and/or important cell manipulations in humans or for the manufacture of an Advanced Therapy Medicinal Product (ATMP) for clinical applications.

Dates and Status

Aug 27, 2024